: SARS-CoV-2 vaccines give rise to positive externalities on population health, society and the economy in addition to protecting the health of vaccinated individuals. Hence, the social value of such a vaccine exceeds its market value. This paper estimates the willingness to pay (WTP) for a hypothetical SARS-CoV-2 vaccine (or shadow prices), in four countries, namely the United States (US), the United Kingdom, Spain and Italy during the first wave of the pandemic when COVID-19 vaccines were in development but not yet approved. WTP estimates are elicited using a payment card method to avoid "yea saying" biases, and we study the effect of protest responses, sample selection bias, as well as the influence of trust in government and risk exposure when estimating the WTP. Our estimates suggest evidence of an average value of a hypothetical vaccine of 100-200 US dollars once adjusted for purchasing power parity. Estimates are robust to a number of checks.

Costa Font, J., Rudisill, C., Harrison, S., Salmasi, L., The social value of a SARS-CoV-2 vaccine: Willingness to pay estimates from four western countries, <<HEALTH ECONOMICS>>, N/A; (N/A): N/A-N/A. [doi:10.1002/hec.4690] [https://hdl.handle.net/10807/236010]

The social value of a SARS-CoV-2 vaccine: Willingness to pay estimates from four western countries

Costa Font, Joan
Primo
;
Salmasi, Luca
Ultimo
2023

Abstract

: SARS-CoV-2 vaccines give rise to positive externalities on population health, society and the economy in addition to protecting the health of vaccinated individuals. Hence, the social value of such a vaccine exceeds its market value. This paper estimates the willingness to pay (WTP) for a hypothetical SARS-CoV-2 vaccine (or shadow prices), in four countries, namely the United States (US), the United Kingdom, Spain and Italy during the first wave of the pandemic when COVID-19 vaccines were in development but not yet approved. WTP estimates are elicited using a payment card method to avoid "yea saying" biases, and we study the effect of protest responses, sample selection bias, as well as the influence of trust in government and risk exposure when estimating the WTP. Our estimates suggest evidence of an average value of a hypothetical vaccine of 100-200 US dollars once adjusted for purchasing power parity. Estimates are robust to a number of checks.
2023
Inglese
Costa Font, J., Rudisill, C., Harrison, S., Salmasi, L., The social value of a SARS-CoV-2 vaccine: Willingness to pay estimates from four western countries, <<HEALTH ECONOMICS>>, N/A; (N/A): N/A-N/A. [doi:10.1002/hec.4690] [https://hdl.handle.net/10807/236010]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/236010
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact